Loading...
•
Mar 31
Clorox Q3 2025 Earnings Report
Clorox reported mixed results amid macroeconomic challenges.
Key Takeaways
Clorox delivered improved gross margins and returned to profitability with $186 million in net income, despite an 8% decline in revenue driven by recent divestitures.
Net sales declined 8% to $1668000000 due to business divestitures.
Gross margin expanded to 44.6%, marking the 10th consecutive quarter of improvement.
Net income reached $186 million compared to a $51 million loss a year ago.
Adjusted EPS fell 15% to $1.45 due to lower sales despite margin gains.
Clorox
Clorox
Clorox Revenue by Segment
Clorox Revenue by Geographic Location
Revenue by Segment
Health and Wellness Revenue
CapyFin.comHousehold Revenue
CapyFin.comLifestyle Revenue
CapyFin.comInternational Revenue
CapyFin.comRevenue by Geographic Location
United States Revenue
CapyFin.comInternational Revenue
CapyFin.com Forward Guidance
Clorox revised its FY2025 outlook to reflect continued geopolitical and macroeconomic pressures, while expecting modest organic growth and strong earnings recovery.
Positive Outlook
- Organic sales expected to grow 4–5% for FY25
- Gross margin improvement forecasted at 150 basis points
- Adjusted EPS projected at $6.95–$7.35
- Expected benefit from ERP-related shipments
- Strategic investments expected to boost long-term productivity
Challenges Ahead
- 1–2% overall revenue decline due to divestitures
- Tariffs expected to increase costs
- Continued macroeconomic and consumer uncertainty
- ERP-related shipment benefits expected to reverse in FY26
- Ongoing cost pressures from trade promotions and inflation
Revenue & Expenses
Visualization of income flow from segment revenue to net income